Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | IONS |
---|---|---|
09:32 ET | 5905 | 36.27 |
09:34 ET | 900 | 36.49 |
09:36 ET | 2307 | 36.5 |
09:38 ET | 1300 | 36.486 |
09:39 ET | 800 | 36.46 |
09:41 ET | 600 | 36.47 |
09:43 ET | 400 | 36.485 |
09:45 ET | 600 | 36.53 |
09:48 ET | 700 | 36.48 |
09:50 ET | 927 | 36.52 |
09:52 ET | 2469 | 36.49 |
09:54 ET | 387 | 36.475 |
09:56 ET | 2417 | 36.39 |
09:57 ET | 600 | 36.36 |
09:59 ET | 200 | 36.33 |
10:01 ET | 900 | 36.355 |
10:03 ET | 1100 | 36.365 |
10:06 ET | 3500 | 36.45 |
10:08 ET | 1935 | 36.485 |
10:10 ET | 2016 | 36.52 |
10:12 ET | 1199 | 36.58 |
10:14 ET | 850 | 36.63 |
10:15 ET | 100 | 36.665 |
10:17 ET | 3832 | 36.77 |
10:19 ET | 7960 | 36.71 |
10:21 ET | 1654 | 36.65 |
10:24 ET | 1400 | 36.55 |
10:26 ET | 929 | 36.54 |
10:28 ET | 2209 | 36.6 |
10:30 ET | 3467 | 36.6 |
10:32 ET | 1252 | 36.53 |
10:33 ET | 1200 | 36.5 |
10:35 ET | 1198 | 36.5 |
10:37 ET | 1200 | 36.54 |
10:39 ET | 512 | 36.52 |
10:42 ET | 1300 | 36.45 |
10:44 ET | 2288 | 36.4 |
10:46 ET | 300 | 36.41 |
10:48 ET | 200 | 36.475 |
10:50 ET | 200 | 36.485 |
10:51 ET | 3405 | 36.48 |
10:53 ET | 1400 | 36.475 |
10:55 ET | 1100 | 36.46 |
10:57 ET | 1200 | 36.45 |
11:00 ET | 300 | 36.45 |
11:02 ET | 1518 | 36.54 |
11:04 ET | 300 | 36.55 |
11:06 ET | 2390 | 36.525 |
11:08 ET | 1300 | 36.505 |
11:09 ET | 1761 | 36.52 |
11:11 ET | 600 | 36.5 |
11:13 ET | 5205 | 36.4 |
11:15 ET | 1243 | 36.43 |
11:18 ET | 1251 | 36.465 |
11:20 ET | 483 | 36.51 |
11:22 ET | 2500 | 36.49 |
11:24 ET | 764 | 36.49 |
11:26 ET | 1887 | 36.52 |
11:27 ET | 300 | 36.52 |
11:29 ET | 300 | 36.53 |
11:31 ET | 100 | 36.56 |
11:33 ET | 1741 | 36.63 |
11:36 ET | 100 | 36.64 |
11:38 ET | 2380 | 36.68 |
11:40 ET | 800 | 36.68 |
11:42 ET | 100 | 36.73 |
11:44 ET | 3087 | 36.77 |
11:45 ET | 200 | 36.79 |
11:47 ET | 2100 | 36.76 |
11:49 ET | 700 | 36.75 |
11:51 ET | 1000 | 36.775 |
11:54 ET | 200 | 36.76 |
11:56 ET | 2539 | 36.71 |
11:58 ET | 2700 | 36.746 |
12:00 ET | 903 | 36.75 |
12:02 ET | 1325 | 36.765 |
12:03 ET | 975 | 36.78 |
12:05 ET | 1970 | 36.86 |
12:07 ET | 600 | 36.94 |
12:09 ET | 1405 | 36.925 |
12:12 ET | 2950 | 36.94 |
12:14 ET | 800 | 36.95 |
12:16 ET | 781 | 36.945 |
12:18 ET | 517 | 36.94 |
12:20 ET | 200 | 36.93 |
12:21 ET | 2500 | 36.895 |
12:23 ET | 2189 | 36.875 |
12:25 ET | 1500 | 36.81 |
12:27 ET | 1548 | 36.82 |
12:30 ET | 1300 | 36.8 |
12:32 ET | 787 | 36.795 |
12:34 ET | 600 | 36.81 |
12:36 ET | 100 | 36.845 |
12:38 ET | 957 | 36.84 |
12:39 ET | 400 | 36.84 |
12:41 ET | 148 | 36.8351 |
12:43 ET | 1873 | 36.83 |
12:45 ET | 500 | 36.82 |
12:50 ET | 700 | 36.81 |
12:52 ET | 300 | 36.81 |
12:54 ET | 780 | 36.81 |
12:56 ET | 200 | 36.825 |
12:57 ET | 982 | 36.83 |
12:59 ET | 400 | 36.82 |
01:01 ET | 1824 | 36.78 |
01:03 ET | 1317 | 36.77 |
01:06 ET | 500 | 36.75 |
01:08 ET | 600 | 36.8 |
01:10 ET | 500 | 36.77 |
01:12 ET | 400 | 36.78 |
01:14 ET | 300 | 36.78 |
01:15 ET | 100 | 36.78 |
01:17 ET | 400 | 36.81 |
01:19 ET | 500 | 36.8 |
01:21 ET | 100 | 36.84 |
01:24 ET | 1220 | 36.84 |
01:26 ET | 400 | 36.87 |
01:28 ET | 2832 | 36.87 |
01:30 ET | 1227 | 36.9 |
01:32 ET | 1709 | 36.85 |
01:33 ET | 1607 | 36.9 |
01:35 ET | 525 | 36.88 |
01:37 ET | 400 | 36.91 |
01:39 ET | 600 | 36.87 |
01:42 ET | 24071 | 36.965 |
01:44 ET | 1663 | 36.95 |
01:46 ET | 3120 | 36.92 |
01:48 ET | 1827 | 36.89 |
01:50 ET | 4722 | 36.92 |
01:51 ET | 11421 | 36.73 |
01:53 ET | 627 | 36.74 |
01:55 ET | 1220 | 36.74 |
01:57 ET | 539 | 36.75 |
02:00 ET | 404 | 36.76 |
02:02 ET | 3590 | 36.81 |
02:04 ET | 520 | 36.83 |
02:06 ET | 1129 | 36.805 |
02:08 ET | 530 | 36.815 |
02:09 ET | 400 | 36.805 |
02:11 ET | 1200 | 36.785 |
02:13 ET | 3722 | 36.765 |
02:15 ET | 1842 | 36.69 |
02:18 ET | 1040 | 36.67 |
02:20 ET | 400 | 36.71 |
02:22 ET | 435 | 36.7162 |
02:24 ET | 400 | 36.71 |
02:26 ET | 1160 | 36.77 |
02:27 ET | 811 | 36.75 |
02:29 ET | 1300 | 36.75 |
02:31 ET | 851 | 36.73 |
02:33 ET | 1157 | 36.74 |
02:36 ET | 600 | 36.74 |
02:38 ET | 600 | 36.712 |
02:40 ET | 25002 | 36.68 |
02:42 ET | 1000 | 36.715 |
02:44 ET | 200 | 36.71 |
02:45 ET | 594 | 36.73 |
02:47 ET | 400 | 36.71 |
02:49 ET | 2255 | 36.74 |
02:51 ET | 200 | 36.75 |
02:54 ET | 1325 | 36.76 |
02:56 ET | 100 | 36.781 |
02:58 ET | 1844 | 36.83 |
03:00 ET | 1393 | 36.8 |
03:02 ET | 600 | 36.845 |
03:03 ET | 2019 | 36.82 |
03:05 ET | 1017 | 36.855 |
03:07 ET | 945 | 36.86 |
03:09 ET | 1200 | 36.88 |
03:12 ET | 200 | 36.885 |
03:14 ET | 2203 | 36.92 |
03:16 ET | 1642 | 36.88 |
03:18 ET | 843 | 36.875 |
03:20 ET | 1701 | 36.9 |
03:21 ET | 1821 | 36.88 |
03:23 ET | 900 | 36.855 |
03:25 ET | 1743 | 36.84 |
03:27 ET | 1047 | 36.88 |
03:30 ET | 1664 | 36.89 |
03:32 ET | 2918 | 36.79 |
03:34 ET | 6012 | 36.58 |
03:36 ET | 4591 | 36.57 |
03:38 ET | 3655 | 36.535 |
03:39 ET | 4702 | 36.53 |
03:41 ET | 3618 | 36.535 |
03:43 ET | 4521 | 36.4 |
03:45 ET | 5857 | 36.4 |
03:48 ET | 2878 | 36.405 |
03:50 ET | 6691 | 36.35 |
03:52 ET | 7727 | 36.48 |
03:54 ET | 11478 | 36.5 |
03:56 ET | 16017 | 36.53 |
03:57 ET | 20995 | 36.52 |
03:59 ET | 28042 | 36.55 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Ionis Pharmaceuticals Inc | 5.3B | -13.7x | --- |
Halozyme Therapeutics Inc | 5.4B | 17.9x | --- |
Apellis Pharmaceuticals Inc | 5.0B | -11.9x | --- |
ACADIA Pharmaceuticals Inc | 2.4B | -1,165.5x | --- |
Azenta Inc | 2.7B | -18.6x | --- |
CRISPR Therapeutics AG | 4.6B | -20.0x | --- |
Ionis Pharmaceuticals, Inc. is engaged in ribonucleic acid (RNA)-targeted therapeutics. The Company has five marketed medicines and a pipeline in neurology, cardiology, and other areas of high patient need. It has nine medicines in Phase III development and multiple additional medicines in early and mid-stage development. The Company’s products include SPINRAZA, QALSODY, WAINUA, TEGSEDI and WAYLIVRA. SPINRAZA is used for the treatment of patients with spinal muscular atrophy (SMA), a progressive, debilitating and often fatal genetic disease. QALSODY is an antisense medicine that is used for the treatment of adult patients with superoxide dismutase 1 amyotrophic lateral sclerosis (SOD1-ALS), a rare, neurodegenerative disorder that causes progressive loss of motor neurons leading to death. WAINUA is a self-administered subcutaneous LIgand-Conjugated Antisense (LICA) medicine used for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis (ATTRv-PN).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.3B |
---|---|
Revenue (TTM) | $776.6M |
Shares Outstanding | 146.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.34 |
EPS | $-2.67 |
Book Value | $2.68 |
P/E Ratio | -13.7x |
Price/Sales (TTM) | 6.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -45.47% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.